Cannabis Law Report

JUNE 4, 2021

Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws.

Data 100

Data Research and Development Clinical Trials Therapy 100

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Veriheal

JANUARY 31, 2023

Researchers Reach a Moral Conundrum According to Vikiana Clement, the former executive director of the Cannabis Education Task Force at Brooklyn’s Medgar Evers College and the researcher, purchasing cannabis from the illicit market may be the “true moral choice” depending on circumstances. This is a data analysis.”

Legalization 104

Legalization Research and Development Business Cannabis 104

Cannabis Law Report

JULY 8, 2021

(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. About cbdMD, Inc. cbdMD, Inc.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. So Releaf app is an app that we released back in 2016.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Veriheal

FEBRUARY 19, 2021

The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. These intertwining factors plaguing cannabis research must be eradicated for the sake of medical cannabis consumers. .

Legalization 89

Legalization Research and Development Safety Data 89

Cannabis Law Report

FEBRUARY 10, 2022

~Gary Allen, CEO, New Frontier Data. Our latest report, 22 for 2022: Cannabis Industry Assertions & Predictions, provides a data-centric blueprint for navigating near-term challenges and positioning for new opportunities in a burgeoning industry.

Data 52

Data Research and Development Hemp Legalization 52

Cannabis Law Report

JULY 29, 2021

Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights.

Research and Development 105

Research and Development Conditions Data Patients 105

Cannabis Law Report

DECEMBER 27, 2019

Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

MAY 29, 2022

is a Canadian company that researches, develops and grows psilocybin-producing mushrooms and functional mushrooms. Ciprick said there needs to be more outcome data and studies on the psilocybin-producing mushrooms to give that comfort level heading forward into introducing a larger market for the product. Optimi Health Corp.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. cannabis researchers. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis.

DEA 52

DEA Research and Development Data Cannabis 52

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

JULY 7, 2021

New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. MYMD-1 is being developed to treat autoimmune and age-related diseases, and to slow aging thereby increasing life-span. Acumen Research and Consulting confirmed TNF-? President, Director and Chief Medical Officer of MyMD.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

NOVEMBER 2, 2021

Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. This emphasis on obtaining more information suggests the FDA is some time away from developing a robust, national CBD enforcement strategy. 01 November 2021. Perkins Coie LLP.

Safety 52

Safety Data Supply Chain Research and Development 52

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Veriheal

JUNE 27, 2023

After over four years of observation, the researchers found no traces of Chronic Obstructive Pulmonary Disease (COPD) —a condition commonly associated with tobacco smoking, characterized by coughing and shortness of breath—whether in developmental or advanced stages.

Research and Development 104

Research and Development Data Collective Vaping 104

Cannabis Law Report

JANUARY 7, 2022

Our NXTecK™ platform is introducing scalable, aggregated, and normalized consumer data with an attribution model, so you know exactly where and how to focus your multi-channel strategies and achieve your digital marketing goals. Free Access to Equio ®. Sponsorship and Marketing Offerings.

Data 52

Data Research and Development Access Retail 52

Cannabis Law Report

DECEMBER 9, 2021

MindMed presented FDA with a working Indications for Use statement (IFU), and a development roadmap. FDA provided key feedback regarding the draft IFU and the research methods that will lay the foundation for regulatory submissions. ” About MindMed.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

OCTOBER 10, 2019

Zefyr Inc , a data analytics firm described in a news announcement as the “Nielsen” of cannabis. Cannabis Big Data Firm to Acquire Zefyr, the ‘Alexa’ of Cannabis. New Frontier Data to Launch Joint Marketing Tech Offering for Mature Market Entrants. Here’s the PR. October 9, 2019.

Data 40

Data Research and Development Business Policy 40

Cannabis Law Report

MARCH 9, 2022

This license expansion will further position Numinus as a recognized global research centre for natural psychedelic medicines, and supplements the current work Numinus is already undertaking on Psilocybe species and inherent synergistic compounds. Harmaline and harmalol naturally occur in B. caapi , while P. viridis , D.

Research and Development 52

Research and Development Therapy Access Medicine 52

Cannabis Law Report

JANUARY 19, 2022

Aligning with the leading market data industry trends in analytical financial services, DeFi, and Index Management allowed the firm to boost its revenue by 45% during 2021, continuing the trend of annual double-digit growth totaling over 560% since 2016. We plan to continue developing our analytical services line. About dxFeed.

Data 52

Data Research and Development Retail Business 52

Cannabis Law Report

APRIL 19, 2019

A female CEO of a cannabis research company is fighting back against controversial Marijuana investor Andy Defrancesco after he started a twitter campaign to allegedly disparage her company and her personal ethics as a CEO. Read on at … Sol Global Chairman Andy Defrancesco sued for Defamation by Cannabis Research Firm: $SOLCF.

Research and Development 61

Research and Development Data Media Banking 61

Cannabis Law Report

AUGUST 9, 2022

August 08, 2022 09:30 ET | Source: Allied Market Research. 08, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global hemp clothing market generated $2.29 … portland, OR, Aug. billion in 2021, and is projected to reach $23.02 billion by 2031, growing at a CAGR of 27.1%

Hemp 52

Hemp Research and Development Data Business 52

Cannabis Law Report

APRIL 28, 2022

Get a bunch of researchers to research it, publish a report for committees to mull over and then ignore. The researchers leading the study were all affiliated with The University of Queensland , and they examined, “historical changes in legalization attitudes and the period-specific individual and external influences on these.”. “A

Legalization 52

Legalization Research and Development Media Data 52

Cannabis Law Report

AUGUST 30, 2021

.–(BUSINESS WIRE)– #cannabis — Dewey Scientific , an agtech innovator pioneering solutions for a sustainable and thriving cannabis industry, announced today the online publication of new data describing the first experimentally validated disease resistance gene in cannabis. Garfinkel, PhD.

Research and Development 103

Research and Development Sativa Agriculture Cultivation 103

Cannabis Law Report

SEPTEMBER 23, 2021

This data will assist Awakn’s progress by enabling a better design and more efficient execution of its clinical program. Awakn will now be able to accelerate its clinical research into a phase IIb randomized controlled trial (RCT) in the U.K. . – September 23, 2021) – Awakn Life Sciences Corp., (NEO:

Research and Development 52

Research and Development Therapy Treatment Data 52

Cannabis Law Report

DECEMBER 26, 2021

Entheon is a biomedical company focused on the research and development of psychedelic drugs and leading-edge biomarkers to provide personalized treatment of addiction disorders. . – December 16, 2021) – Entheon Biomedical Corp. About Entheon Biomedical Corp.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

MAY 27, 2021

Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing… Read More. Wesana Health Holdings Inc.

Data 59

Data 59

Cannabis Law Report

DECEMBER 5, 2019

New Brunswick, Canada, marijuana publishing company Civilized Worldwide is “temporarily” laying off its entire workforce ahead of a pending sale to Washington DC-based New Frontier Data. New Frontier, a data and analytics company, said in a news release it has completed its diligence and will move forward with its acquisition of Civilized.

Data 59

Data Research and Development Media Business 59

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Big Data Improves Distribution in the Marijuana Industry. Source: [link]. Global Cannabis Applications Corp.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

JANUARY 31, 2022

TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. Numinus Wellness Inc.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

SEPTEMBER 9, 2021

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Cross Channel Measurement in a Time of Data Collection Challenges. . Pivoting on New Product Development. .

Events 102

Events Wellness and Beauty Data Media 102

Cannabis Law Report

DECEMBER 18, 2021

Most MPs believe that it is time to update UK drug laws “based on evidence”, new polling data commissioned by the Conservative Drug Policy Reform Group (CDPRG) published today shows. The CDPRG is already in talks with Ministers to further this as the new drugs strategy develops. Letter+to+Prime+Minister+26Nov2021. THE REPORT.

Law 52

Law Research and Development Policy Data 52

Canna Law Blog

SEPTEMBER 24, 2022

Using scientifically and epidemiologically valid methods and standards for policy development. First, the OCM clearly was looking for someone with a background in data analytics. Prior to be approved and hired by the OCM, Mr. Kagia was the Chief Knowledge Officer for New Frontier Data.

Policy 72

Policy Research and Development Data Legislation 72